Scribe Therapeutics, Inc. (SCTX) stock
SCTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026
$15.77+0.40 (+2.60%)
Close on Nov 17, 2026Market cap $39.19MP/E –Yield –
Scribe Therapeutics profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -337.7% | – |
| Q2 FY2025 | Jun 30, 2025 | -202.2% | – |
See a number that looks wrong?